Update on Colorectal Cancer.
An estimated 129,400 new cases of colorectal cancer occurred in the United States during 1999. The lifetime risk of developing this cancer is 2.5 to 5 percent in the general population but two to three times higher in persons who have a first-degree relative with colon cancer or an adenomatous
Gender and Race/Ethnicity Affect the Cost-Effectiveness of Colorectal Cancer Screening
Background and Aims: Colorectal cancer screening beginning at age 50 is recommended for all Americans considered at average risk for the development of colorectal cancer regardless of gender or race/ethnicity. We determined the influence of gender and race/ethnicity on the costeffectiveness of
BREAST AND COLORECTAL CANCER RISK COMMUNICATION APPROACHES WITH LOW-INCOME AFRICAN-AMERICAN AND HISPANIC WOMEN: IMPLICATIONS FOR HEALTHCARE PROVIDERS
Background: Information on breast and colorectal cancer risk factors is widely available to women and the physicians who provide their healthcare; however, many women are unable to identify the major risk factors, continue to misperceive their personal risk of developing these cancers, and do not
Colorectal cancer screening: today and tomorrow.
Abstract: Colorectal cancer remains a disease with significant morbidity and mortality. However, the prognosis can be greatly improved with early detection. Here, we review the current screening modalities and guidelines for patients at average, moderate, and high risk for colorectal cancer. New
The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy
Colorectal cancer screening beginning at age 50 is recommended for all Americans considered at "average" risk for the development of colorectal cancer either with flexible sigmoidoscopy and fecal occult blood testing (FOBT) or with colonoscopy. Patients who elect flexible sigmoidoscopy and FOBT
Screening preferences for colorectal cancer: a patient demographic study.
Background: Colorectal cancer is a leading cause of cancer-related death. Screening for colorectal cancer is a rational and cost-effective strategy for reducing the incidence of colorectal cancer and related mortality. Despite endorsement by academic and health care organizations, patient awareness
Increasing Colorectal Cancer Screening among African Americans, Linking Risk Perception to Interventions Targeting Patients, Communities and Clinicians
Colorectal cancer (CRC) screening remains significantly underutilized by African Americans despite their increased risk compared to whites. The purpose of this article is to review recent research on patterns of screening, perceptions of CRC screening methods and outcomes of seven intervention
Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery.
Colorectal cancer is the second leading cause of cancer mortality in the United States and is estimated to account for 56,600 deaths in 2002 (Jemal et al. 2002). Important racial and ethnic differences exist in colorectal cancer incidence and mortality. While U.S. blacks have a 12 percent higher
Colorectal cancer: an overview of the epidemiology, risk factors, symptoms, and screening guidelines.(Disease/Disorder overview)
Some common misconceptions exist concerning which individuals develop colorectal cancer (see Table 1). The purpose of this column is to provide an overview of the epidemiology, risk factors, symptoms, screening guidelines, and health care implications for this type of cancer. Colorectal cancer is
Surveillance of the colorectal cancer disparities among demographic subgroups: a spatial analysis.
Objective: The literature suggests that colorectal cancer mortality in Texas is distributed inhomogeneously among specific demographic subgroups and in certain geographic regions over an extended period. To understand the extent of the demographic and geographic disparities, the present study
